Blogs | MedChemExpress

STF-31 is a Selective GLUT1 Inhibitor and Used for Efferocytosis Rearch

STF-31 is a potent ans selective inhibitor of GLUT1 that inhibit glucose uptake in renal cell carcinoma (RCC) 4 cells.
JS25, a Selective and Covalent BTK Inhibitor, Acts by Segregating Tyr551

JS25 is a selective and covalent BTK inhibitor in hematological cancer. JS25 has blood brain barrier crossing property.
Abexinostat is an Orally Available Pan-HDAC Inhibitor

Abexinostat, a potent and broad-spectrum inhibitor of histone deacetylases, can be used for the research of cancer.
JBJ-09-063 is a Mutant-Selective Allosteric EGFR Inhibitor

JBJ-09-063 is a mutant-selective allosteric EGFR inhibitor. JBJ-09-063 can be used for EGFR-mutant lung cancer research.
STX-0119 is a Selective, Orally Active STAT3 Dimerization Inhibitor

STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 shows potent antitumor activity.
GN25 is a Specific p53-Snail Binding Inhibitor with Antitumor Effects

GN25 is a specific inhibitor of p53-Snail binding and shows anti-tumor effect against K-Ras-mutated cancer.
ABT-510 is an Anti-Angiogenic Thrombospondin Peptide

ABT-510, a peptide analog of thrombospondin-1 (TSP-1), can block angiogenesis in vitro and in vivo, and slow tumor growth.
BI-0474 is a Potent KRAS G12C inhibitor

BI-0474 is a potent KRAS G12C inhibitor and exhibits good anti-proliferative activity against NCI-H358 cells carrying the G12C mutation.
Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody

Serplulimab is a humanized monoclonal anti-PD-1 antibody and has the potential for the research of small cell lung cancer.
LY3177833 is an Orally Active CDC7 and pMCM2 Inhibitor

LY3177833 is an orally active CDC7 and pMCM2 inhibitor with IC50 values of 3.3 nM and 290 nM, respectively. LY3177833 is a senescence inducer

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (14)